Clinical trial / 2015
Pomegranate extract did not significantly prolong prostate-specific antigen doubling time versus placebo.
In a randomized trial with 183 men showing rising PSA levels after prostate cancer therapy, subjects received pomegranate extract (n=102), placebo (n=64), or juice (n=17). Median PSA doubling time increased across all groups: 11.1 to 15.6 months with placebo, 12.9 to 14.5 months with extract, and 12.7 to 20.3 months with juice, but differences between groups were not statistically significant (P>0.05).
- Study type
- Randomized controlled trial
- Who was studied
- 183 men with rising PSA levels after prostate cancer therapy
- What was measured
- Change in prostate-specific antigen doubling time
THE PAPER
A randomized, double-blind, placebo-controlled study of the effects of pomegranate extract on rising PSA levels in men following primary therapy for prostate cancer.
Pantuck AJ, Pettaway CA, Dreicer R, Corman J, Katz A, Ho A, Aronson W, Clark W, Simmons G, Heber D. Prostate Cancer Prostatic Dis, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.